Skip to main content
logo
Imexpharm Corporation (HOSE:IMP)
Vietnam flag Vietnam · Delayed Price · Currency is VND
39,800
+900 (2.31%)
At close: Aug 28, 2026

Imexpharm Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Net Income
360,327349,138320,862299,556223,540189,095
Depreciation & Amortization
101,031102,976105,63682,64260,38660,412
Other Amortization
2,5151,742----
Loss (Gain) From Sale of Assets
-20,371-19,864-8,759-22,410-19,861-18,628
Other Operating Activities
-48,342-147,657-128,550-32,171-6,126-45,582
Change in Accounts Receivable
-22,824-21,484-83,307-30,53420,136115,759
Change in Inventory
-6,81725,990-6,181-260,74952,398-66,129
Change in Accounts Payable
-110,83734,18720,27825,48139,580-2,831
Change in Other Net Operating Assets
33,203-270,857-3,711-101,3517,018-2,159
Operating Cash Flow
287,88654,171216,268-39,535378,603234,881
Operating Cash Flow Growth
285.75%-74.95%--61.19%221.08%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Capital Expenditures
-36,297-26,879-96,771-63,530-99,353-52,857
Sale of Property, Plant & Equipment
418.971,1274,8322,533582.738,655
Investment in Securities
-100,232-70,102-42,935118,300-118,327-244,945
Other Investing Activities
17,00119,2707,67521,81717,79410,106
Investing Cash Flow
-106,677-76,584-127,19979,121-199,304-83,142

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Short-Term Debt Issued
---229,73959,803-
Long-Term Debt Issued
-666,889387,994--324,785
Total Debt Issued
217,254666,889387,994229,73959,803324,785
Short-Term Debt Repaid
----275,298--
Long-Term Debt Repaid
--540,232-351,294--231,514-190,282
Total Debt Repaid
-426,640-540,232-351,294-275,298-231,514-190,282
Net Debt Issued (Repaid)
-209,386126,65836,700-45,558-171,711134,503
Common Dividends Paid
-77,004-77,004-70,005-66,672-100,007-100,007
Financing Cash Flow
-286,39049,653-33,305-112,230-271,71834,496

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-43.77-30.6619.18-0.59-9.19-230.63
Net Cash Flow
-105,22527,21055,783-72,645-92,428186,004

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Free Cash Flow
251,58827,292119,497-103,064279,250182,024
Free Cash Flow Growth
939.32%-77.16%--53.41%-
Free Cash Flow Margin
10.83%1.12%5.42%-5.17%16.99%14.37%
Free Cash Flow Per Share
1633.60177.21775.91-669.211813.191181.89
Levered Free Cash Flow
242,427380,110145,454-69,934274,201211,391
Unlevered Free Cash Flow
251,118390,423147,635-66,162276,573214,826

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Cash Interest Paid
19,03816,3823,4916,7004,4754,227
Cash Income Tax Paid
97,055101,01470,80683,99259,62445,310
Change in Working Capital
-107,275-232,165-72,921-367,153120,66449,583